Finerenone (Kerendia)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Finerenone (Kerendia), covering 2025-09-04 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria [Phase 3]